News & AnalysisBiomedicine

Pharma Firms Push for Sharing of Cancer Trial Data

Science  05 Oct 2012:
Vol. 338, Issue 6103, pp. 29
DOI: 10.1126/science.338.6103.29

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

A consortium of pharmaceutical companies hopes to improve the success rate of experimental cancer therapies by getting cancer researchers to share data from clinical trials. Called DataSphere, the effort aims to create a repository of data sets from cancer trials. The initiative has been kick-started with two data sets contributed by pharma giant Sanofi. Other companies, as well as universities, are expected to contribute data in the coming months. The architects of the effort hope to make the repository available to outside researchers by April of next year.

Related Content